title: Extended use of topical nasal decongestants.
abstract: Use of sympathomimetic topical nasal decongestants to treat nasal obstruction is usually restricted to 3 to 5 days to avoid potential rebound swelling (rhinitis medicamentosa). In this study, 10 healthy volunteers used oxymetazoline (long-acting topical nasal decongestant) nightly for 4 weeks. Subjects who used antihistamines, oral or topical decongestants, or systemic steroids or who had active sinusitis were excluded from the study. Weekly history, physical examination, and anterior rhinomanometry revealed no adverse effects. Eight (80%) subjects developed nightly nasal obstruction a few hours before the evening dose; the obstruction resolved within 48 hours if no more decongestant was used. All subjects remained responsive to oxymetazoline 4 weeks and 8 weeks after the study began. This finding suggests that long-acting decongestants may be safely used for longer than the recommended 3 to 5 days without adverse effects if used once nightly.
authors.affiliation: Department of Otolaryngology, University of Texas Medical Branch, Galveston 77550-0521, USA.
authors.forename: J K
authors.initials: JK
authors.lastname: Yoo
authors.forename: H
authors.initials: H
authors.lastname: Seikaly
authors.forename: K H
authors.initials: KH
authors.lastname: Calhoun
mesh_terms: D006801:Humans; D014663:Nasal Decongestants / Q000008:administration & dosage* / Q000009:adverse effects; D015508:Nasal Obstruction / Q000139:chemically induced; D010109:Oxymetazoline / Q000008:administration & dosage* / Q000009:adverse effects; D012220:Rhinitis / Q000139:chemically induced; D013566:Sympathomimetics / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D014663:Nasal Decongestants; D013566:Sympathomimetics; D010109:Oxymetazoline